Differential tumor inhibitory effects induced by HER3 extracellular subdomain-specific mouse monoclonal antibodies by Hassani, Danesh, Jeddi-Tehrani, Mahmood, Yousefi, Parisa, Mansouri-Fard, Samaneh, Mobini, Maryam, Ahmadi-Zare, Hengameh, Golsaz-Shirazi, Forough, Amiri, Mohammad Mehdi, Shokri, Fazel

Get full text

A Novel Anti-HER2 Bispecific Antibody With Potent Tumor Inhibitory Effects In Vitro and In Vivo by Mohammadi, Mehdi, Jeddi-Tehrani, Mahmood, Golsaz-Shirazi, Forough, Arjmand, Mohammad, Bahadori, Tannaz, Judaki, Mohammad Ali, Shiravi, Fariba, Zare, Hengameh Ahmadi, Haghighat, Farzaneh Notash, Mobini, Maryam, Amiri, Mohammad Mehdi, Shokri, Fazel

Get full text

Comparison of different transient gene expression systems for the production of a new humanized anti-HER2 monoclonal antibody (Hersintuzumab) by Roshani, Ali, Mohammadi, Mehdi, Bahadori, Tannaz, Ahmadi Zare, Hengameh, Judaki, Mohammad Ali, Mobini, Maryam, Golsaz-Shirazi, Forough, Jeddi-Tehrani, Mahmood, Amiri, Mohammad Mehdi, Shokri, Fazel

Get full text

Epitope mapping of severe acute respiratory syndrome coronavirus 2 neutralizing receptor binding domain-specific monoclonal antibodies by Maghsood, Faezeh, Amiri, Mohammad Mehdi, Zarnani, Amir-Hassan, Salimi, Vahid, Kardar, Gholam Ali, Khoshnoodi, Jalal, Mobini, Maryam, Ahmadi Zare, Hengameh, Ghaderi, Abbas, Jeddi-Tehrani, Mahmood, Schmidt, Sylvie, Laumond, Géraldine, Moog, Christiane, Shokri, Fazel

Get full text

Potent synergistic anti-tumor activity of a novel humanized anti-HER2 antibody hersintuzumab in combination with trastuzumab in xenograft models by Shiravi, Fariba, Mohammadi, Mehdi, Golsaz-Shirazi, Forough, Bahadori, Tannaz, Judaki, Mohammad Ali, Fatemi, Forough, Zare, Hengameh Ahmadi, Haghighat, Farzaneh Notash, Mobini, Maryam, Jeddi-Tehrani, Mahmood, Amiri, Mohammad Mehdi, Shokri, Fazel

Get full text